Found: 8
Select item for more details and to access through your institution.
Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline.
- Published in:
- Alzheimer's Research & Therapy, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13195-022-01143-z
- By:
- Publication type:
- Article
Clinical utility of an antibody‐free LC‐MS method to detect brain amyloid deposition in cognitively unimpaired individuals from the screening visit of the A4 Study.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023, v. 15, n. 2, p. 1, doi. 10.1002/dad2.12451
- By:
- Publication type:
- Article
Safety, tolerability and immunogenicity of an active anti-Aβ<sub>40</sub> vaccine (ABvac40) in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase I trial.
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, p. 1, doi. 10.1186/s13195-018-0340-8
- By:
- Publication type:
- Article
Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity.
- Published in:
- Frontiers in Aging Neuroscience, 2023, v. 15, p. 1, doi. 10.3389/fnagi.2023.1126799
- By:
- Publication type:
- Article
AB1601 Phase 2 Study of ABvac40, an Anti‐Aβ40 Vaccine: Safety and Immunogenicity of a Cross‐Over Extension.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082952
- By:
- Publication type:
- Article
Contribution of clinical information to the predictive performance of plasma Aβ levels for Aβ PET positivity.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082471
- By:
- Publication type:
- Article
ABTEST‐IA: A new reliable tool for the quantification of Aβ40 and Aβ42 in CSF.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.065546
- By:
- Publication type:
- Article
Aβ42/Aβ40 ratio in plasma predicts amyloid‐PET status in amnestic‐MCI patients.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057231
- By:
- Publication type:
- Article